TipRanks
Advertisement
Advertisement

GMAB Stock Latest News

Genmab price target raised to $42 from $35 at Morgan Stanley
The FlyGenmab price target raised to $42 from $35 at Morgan Stanley
23h ago
GMAB
Genmab Maintained at Buy as DARZALEX Strength and Oncology Pipeline Support Unchanged $50 Price Target
PremiumRatings
Genmab Maintained at Buy as DARZALEX Strength and Oncology Pipeline Support Unchanged $50 Price Target
2d ago
GMAB
Genmab Reports USD 4.2 Billion in Q3 2026 DARZALEX Net Sales
PremiumCompany Announcements
Genmab Reports USD 4.2 Billion in Q3 2026 DARZALEX Net Sales
8d ago
6K
GMAB
Genmab reports Q3 net sales of Darzalex $4.24B
PremiumThe Fly
Genmab reports Q3 net sales of Darzalex $4.24B
8d ago
JNJ
GMAB
Genmab: Packed Catalyst Calendar and Late-Stage Pipeline Upside Drive Buy Rating and Price Target Increase to DKK 2,850
PremiumRatings
Genmab: Packed Catalyst Calendar and Late-Stage Pipeline Upside Drive Buy Rating and Price Target Increase to DKK 2,850
13d ago
GMAB
Genmab Grants Restricted Stock Units to Board After Extraordinary General Meeting
PremiumCompany AnnouncementsGenmab Grants Restricted Stock Units to Board After Extraordinary General Meeting
14d ago
6K
GMAB
Genmab price target raised to $45 from $40 at Truist
Premium
The Fly
Genmab price target raised to $45 from $40 at Truist
14d ago
GMAB
Genmab price target raised to $58 from $54 at Guggenheim
Premium
The Fly
Genmab price target raised to $58 from $54 at Guggenheim
14d ago
GMAB
Genmab price target raised to $50 from $40 at H.C. Wainwright
PremiumThe Fly
Genmab price target raised to $50 from $40 at H.C. Wainwright
14d ago
GMAB
Genmab price target raised to DKK 2,850 from DKK 2,500 at BofA
PremiumThe Fly
Genmab price target raised to DKK 2,850 from DKK 2,500 at BofA
15d ago
GMAB
Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL
PremiumCompany Announcements
Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL
16d ago
6K
GMAB
Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study
PremiumThe Fly
Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study
16d ago
ABBV
GMAB
Genmab: Buy Rating Reaffirmed on Strong Rina-S Phase II Ovarian Cancer Data; DKK 2,500 Price Target Maintained
PremiumRatingsGenmab: Buy Rating Reaffirmed on Strong Rina-S Phase II Ovarian Cancer Data; DKK 2,500 Price Target Maintained
16d ago
GMAB
Genmab price target raised to $54 from $45 at Guggenheim
Premium
The Fly
Genmab price target raised to $54 from $45 at Guggenheim
16d ago
GMAB
Genmab announces Rina-S Phase 2 RAINFOL-1 trial results
Premium
The Fly
Genmab announces Rina-S Phase 2 RAINFOL-1 trial results
17d ago
GMAB
Genmab Discloses Darwin Global as 5.11% Major Shareholder
PremiumCompany Announcements
Genmab Discloses Darwin Global as 5.11% Major Shareholder
19d ago
6K
GMAB
Genmab Updates Capital Structure and Articles of Association in September 2026 SEC Filing
PremiumCompany Announcements
Genmab Updates Capital Structure and Articles of Association in September 2026 SEC Filing
22d ago
6K
GMAB
Genmab Grants New Employee Restricted Stock Units and Warrants
PremiumCompany Announcements
Genmab Grants New Employee Restricted Stock Units and Warrants
27d ago
6K
GMAB
Genmab Updates Articles of Association, Preserves Broad Capital-Raising Powers
PremiumCompany Announcements
Genmab Updates Articles of Association, Preserves Broad Capital-Raising Powers
1M ago
6K
GMAB
Genmab Raises Share Capital via Employee Warrant Exercise
PremiumCompany AnnouncementsGenmab Raises Share Capital via Employee Warrant Exercise
1M ago
6K
GMAB
Genmab Calls October Extraordinary General Meeting to Address Board Remuneration and Shareholder Outreach
Premium
Company Announcements
Genmab Calls October Extraordinary General Meeting to Address Board Remuneration and Shareholder Outreach
1M ago
6K
GMAB
Genmab price target raised to DKK 2,500 from DKK 2,250 at Deutsche Bank
Premium
The Fly
Genmab price target raised to DKK 2,500 from DKK 2,250 at Deutsche Bank
2M ago
GMAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >